OLN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Olin Corp (OLN) is not a strong buy at the moment for a long-term beginner investor. The company is facing significant financial challenges, as evidenced by its poor Q4 2025 performance, and there are no strong positive catalysts or signals to suggest immediate upside potential. While analysts have raised price targets recently, the ratings remain neutral overall, and insider selling is a concerning factor. Given the investor's preference for long-term investments, it would be prudent to wait for clearer signs of financial recovery or stronger growth potential before committing capital.
The technical indicators are mixed. While the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the MACD is negative and expanding downward, and the RSI is neutral at 43.31. The stock is trading near a key pivot level of 28.316, with resistance at 29.909 and support at 26.723. This suggests limited immediate upside potential.
Analysts have raised price targets recently, with some citing potential price increases in electrochemical unit margins and caustic soda prices. Wells Fargo upgraded the stock to Overweight with a $35 price target, citing a stronger outlook for 2026.
Insiders are selling heavily, with a 2449.48% increase in selling activity over the last month. The company's financials are deteriorating significantly, with a -1440.19% YoY drop in net income and a -1500.00% YoY drop in EPS. No recent news or event-driven catalysts are present to support a bullish case.
Olin's Q4 2025 financial performance was poor, with revenue dropping -0.37% YoY to $1.665 billion, net income plummeting to -$143.4 million (-1440.19% YoY), and EPS falling to -1.26 (-1500.00% YoY). Gross margin also dropped significantly to 2.43, down -75.92% YoY.
Analysts have raised price targets recently, with the highest target being $35 from Wells Fargo. However, most ratings remain Neutral or Sector Perform, indicating limited confidence in the stock's near-term upside. The upgrades are primarily based on potential improvements in commodity chemical pricing and margins rather than strong company fundamentals.
